VENTALEON
Ventaleon is developing inhaled treatments against viral infections. The Company’s lead therapy, is an inhaled LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well-known acetyl salicylic acid (Aspirin®), suitable as an ingredient for inhalable aerosol, has completed Phase II clinical trials to treat severe influenza. A proof-of-concept study in influenza patients with moderate to severe symptoms demonstrated more rapid symptom decline when administered via inhaled LASAG compared to standard of care. The Company is currently preparing to enter a pivotal clinical trial with inhaled LASAG. Ventaleon was founded as a spin-off from Activaero, a leading specialist in aerosol inhalation therapies and technologies, in 2012
VENTALEON
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Gemünden, Bayern, Germany
Country:
Germany
Website Url:
http://www.ventaleon.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Common Name Invalid Parallels Plesk Panel GlobalSign AlphaSSL InterNetX DNS
Similar Organizations
AAVantgarde Bio
AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
ApoH-Technologies
ApoH-Technologies proposes sample pretreatment solutions.
AspiAir GmbH
AspiAir GmbH is developing inhaled treatments with acetylsalicylic acid in different indications.
Stayble Therapeutics
Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.
Vironexx
Vironexx develops innovative therapies for prevention and treatment of viral infections.
Investors List
LSP BioVentures
LSP BioVentures investment in Venture Round - Ventaleon
Abalis Finance
Abalis Finance investment in Venture Round - Ventaleon
BayBG Venture Capital
BayBG Venture Capital investment in Venture Round - Ventaleon
Official Site Inspections
http://www.ventaleon.com
- Host name: saturn.cycom.it
- IP address: 85.236.63.4
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Ventaleon"
Ventaleon - Crunchbase Company Profile & Funding
Ventaleon is developing inhaled treatments against viral infections. The Company’s lead therapy, is an inhaled LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well …See details»
Ventaleon
Ventaleon GmbH has discontinued its operating business in 2020.See details»
Ventaleon Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Ventaleon. Use the PitchBook Platform to explore the full profile.See details»
Ventaleon - Overview, News & Similar companies | ZoomInfo.com
Ventaleon contact info: Phone number: +49 64535853040 Website: www.ventaleon.com What does Ventaleon do? Ventaleon GmbH is a biotechnology company focused on the …See details»
Ventaleon GmbH - LinkedIn
Ventaleon GmbH | 35 followers on LinkedIn. Ventaleon GmbH is a Drug Development company located in 29 Robert-Koch-Allee, Gauting, Bavaria, Germany.See details»
Ventaleon Company Profile - Office Locations, Competitors, …
Ventaleon has 5 employees at their 1 location. See insights on Ventaleon including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Ventaleon GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ventaleon GmbH of Gemünden (Wohra), Hessen. Get the latest business insights from Dun & Bradstreet.See details»
Ventaleon - VentureRadar
Website: http://www.ventaleon.com/ Ventaleon is developing inhaled treatments against viral infections. The Company’s lead therapy, is an inhaled LASAG (D,L-lysine acetylsalicylate • …See details»
Ventaleon GmbH - Company Profile and News - Bloomberg Markets
Company profile page for Ventaleon GmbH including stock price, company news, executives, board members, and contact informationSee details»
Ventaleon - Crunchbase
Ventaleon is developing inhaled treatments against viral infections.See details»
Ventaleon - Products, Competitors, Financials, Employees, …
Ventaleon develops inhaled treatments for viral infections. Use the CB Insights Platform to explore Ventaleon's full profile.See details»
Ventaleon - Funding, Financials, Valuation & Investors - Crunchbase
Jan 1, 2015 · Ventaleon has raised 2 rounds. Their latest funding was raised on Jan 1, 2015 from a Venture - Series Unknown round. Ventaleon is funded by 3 investors. LSP BioVentures and …See details»
Ventaleon - EQT Group
Latest news. 24 September 2024 EQT Active Core Infrastructure fund holds final close; 24 September 2024 EQT Welcomes Sixth Street as Strategic Investor in EdgeConneXSee details»
Ventaleon GmbH Reports Clear Clinical Progress And Additions
Gemuenden, Germany, 12 October, 2017 - Ventaleon GmbH, a biotechnology company focusing on the development of inhaled treatments against viral infections, provided today a clinical and …See details»
Ventaleon CEO and Key Executive Team | Craft.co
Ventaleon's Chief Executive Officer is Stefan Degenhardt. Other executives include Sebastian Canisius, Chief Medical Officer. See the full leadership team at Craft.See details»
Ventaleon GmbH Initiates Challenge Trial with Inhaled Flu …
Ventaleon GmbH, a biotechnology company focusing on the development of inhaled treatments against viral infections, today announced the initiation of a human challenge trial for its flu …See details»
Glycine/lysine acetylsalicylate inhalation - Ventaleon
Jul 29, 2016 · Ventaleon (a joint venture between Vectura and an investment syndicate) is developing inhaled glycine/lysine acetylsalicylate for the treatment of severeSee details»
Ventaleon | VentureRadar
Website: http://www.ventaleon.com/ Ventaleon is developing inhaled treatments against viral infections. The Company’s lead therapy, is an inhaled LASAG (D,L-lysine acetylsalicylate • …See details»
Ventaleon - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Ventaleon uses 8 technology products and services including Office 365, GoDaddy, and DigiCert, according to G2 Stack. Ventaleon is actively using 7 technologies for its website, according to …See details»
Ventaleon Stock Price, Funding, Valuation, Revenue ... - CB Insights
See Ventaleon funding rounds, investors, investments, exits and more. Evaluate their financials based on Ventaleon's post-money valuation and revenue.See details»